Literature DB >> 18472015

P53, cyclin-dependent kinase and abnormal amplification of centrosomes.

Kenji Fukasawa1.   

Abstract

Centrosomes play a critical role in formation of bipolar mitotic spindles, an essential event for accurate chromosome segregation into daughter cells. Numeral abnormalities of centrosomes (centrosome amplification) occur frequently in cancers, and are considered to be the major cause of chromosome instability, which accelerates acquisition of malignant phenotypes during tumor progression. Loss or mutational inactivation of p53 tumor suppressor protein, one of the most common mutations found in cancers, results in a high frequency of centrosome amplification in part via allowing the activation of the cyclin-dependent kinase (CDK) 2-cyclin E (as well as CDK2-cyclin A) which is a key factor for the initiation of centrosome duplication. In this review, the role of centrosome amplification in tumor progression, and mechanistic view of how centrosomes are amplified in cells through focusing on loss of p53 and aberrant activities of CDK2-cyclins will be discussed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18472015      PMCID: PMC2647860          DOI: 10.1016/j.bbcan.2008.04.002

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  86 in total

1.  Induction of centrosome amplification in p53 siRNA-treated human fibroblast cells by radiation exposure.

Authors:  Kenji Kawamura; Nobuyo Morita; Chizue Domiki; Kozaburo Fujikawa-Yamamoto; Mitsumasa Hashimoto; Kuniyoshi Iwabuchi; Koji Suzuki
Journal:  Cancer Sci       Date:  2006-04       Impact factor: 6.716

2.  MEK1 and MEK2, different regulators of the G1/S transition.

Authors:  Siegfried Ussar; Tilman Voss
Journal:  J Biol Chem       Date:  2004-07-28       Impact factor: 5.157

3.  Centrosome-associated Chk1 prevents premature activation of cyclin-B-Cdk1 kinase.

Authors:  Alwin Krämer; Niels Mailand; Claudia Lukas; Randi G Syljuåsen; Christopher J Wilkinson; Erich A Nigg; Jiri Bartek; Jiri Lukas
Journal:  Nat Cell Biol       Date:  2004-08-15       Impact factor: 28.824

4.  Haploinsufficiency of RAD51B causes centrosome fragmentation and aneuploidy in human cells.

Authors:  Osamu Date; Mari Katsura; Mari Ishida; Takashi Yoshihara; Aiko Kinomura; Taijiro Sueda; Kiyoshi Miyagawa
Journal:  Cancer Res       Date:  2006-06-15       Impact factor: 12.701

5.  Cyclin-dependent kinase 2 is dispensable for normal centrosome duplication but required for oncogene-induced centrosome overduplication.

Authors:  A Duensing; Y Liu; M Tseng; M Malumbres; M Barbacid; S Duensing
Journal:  Oncogene       Date:  2006-05-11       Impact factor: 9.867

6.  Combined loss of Cdk2 and Cdk4 results in embryonic lethality and Rb hypophosphorylation.

Authors:  Cyril Berthet; Kimberly D Klarmann; Mary Beth Hilton; Hyung Chan Suh; Jonathan R Keller; Hiroaki Kiyokawa; Philipp Kaldis
Journal:  Dev Cell       Date:  2006-05       Impact factor: 12.270

7.  Suppression of centrosome amplification after DNA damage depends on p27 accumulation.

Authors:  Eiji Sugihara; Masayuki Kanai; Soichiro Saito; Takayuki Nitta; Hideo Toyoshima; Keiko Nakayama; Keiichi I Nakayama; Kenji Fukasawa; Manfred Schwab; Hideyuki Saya; Masanao Miwa
Journal:  Cancer Res       Date:  2006-04-15       Impact factor: 12.701

8.  Centrosome amplification induced by DNA damage occurs during a prolonged G2 phase and involves ATM.

Authors:  Helen Dodson; Emer Bourke; Liam J Jeffers; Paola Vagnarelli; Eiichiro Sonoda; Shunichi Takeda; William C Earnshaw; Andreas Merdes; Ciaran Morrison
Journal:  EMBO J       Date:  2004-09-09       Impact factor: 11.598

9.  p21-Mediated nuclear retention of cyclin B1-Cdk1 in response to genotoxic stress.

Authors:  Fabienne Baus Charrier-Savournin; Marie-Thérèse Château; Véronique Gire; John Sedivy; Jacques Piette; Vjekoslav Dulic
Journal:  Mol Biol Cell       Date:  2004-06-04       Impact factor: 4.138

10.  p16(INK4a) prevents centrosome dysfunction and genomic instability in primary cells.

Authors:  Kimberly M McDermott; Jianmin Zhang; Charles R Holst; B Krystyna Kozakiewicz; Veena Singla; Thea D Tlsty
Journal:  PLoS Biol       Date:  2006-02-14       Impact factor: 8.029

View more
  42 in total

Review 1.  Such small hands: the roles of centrins/caltractins in the centriole and in genome maintenance.

Authors:  Tiago J Dantas; Owen M Daly; Ciaran G Morrison
Journal:  Cell Mol Life Sci       Date:  2012-03-30       Impact factor: 9.261

Review 2.  Illicit survival of cancer cells during polyploidization and depolyploidization.

Authors:  I Vitale; L Galluzzi; L Senovilla; A Criollo; M Jemaà; M Castedo; G Kroemer
Journal:  Cell Death Differ       Date:  2010-11-12       Impact factor: 15.828

Review 3.  Centrosomes and cancer: revisiting a long-standing relationship.

Authors:  Pierre Gönczy
Journal:  Nat Rev Cancer       Date:  2015-11       Impact factor: 60.716

4.  Amplified centrosomes may underlie aggressive disease course in pancreatic ductal adenocarcinoma.

Authors:  Karuna Mittal; Angela Ogden; Michelle D Reid; Padmashree C G Rida; Sooryanarayana Varambally; Ritu Aneja
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

5.  Centrosome Aberration Frequency and Disease Association in B-Acute Lymphoblastic Leukemia.

Authors:  Lily S Kerketta; Kanjaksha Ghosh; Anita Nadkarni; Manisha Madkaikar; Babu Rao Vundinti
Journal:  In Vivo       Date:  2017 Mar-Apr       Impact factor: 2.155

6.  Specific overexpression of cyclin E·CDK2 in early preinvasive and primary breast tumors in female ACI rats induced by estrogen.

Authors:  S John Weroha; Wilma L Lingle; Yan Hong; Sara Antonia Li; Jonathan J Li
Journal:  Horm Cancer       Date:  2010-02-10       Impact factor: 3.869

Review 7.  Turning the headlights on novel cancer biomarkers: Inspection of mechanics underlying intratumor heterogeneity.

Authors:  Michelle McBride; Padmashree C G Rida; Ritu Aneja
Journal:  Mol Aspects Med       Date:  2015-05-27

8.  p53 centrosomal localization diagnoses ataxia-telangiectasia homozygotes and heterozygotes.

Authors:  Andrea Prodosmo; Andrea De Amicis; Cecilia Nisticò; Mario Gabriele; Giuliana Di Rocco; Laura Monteonofrio; Maria Piane; Enrico Cundari; Luciana Chessa; Silvia Soddu
Journal:  J Clin Invest       Date:  2013-02-01       Impact factor: 14.808

9.  Cdk2 and Cdk4 regulate the centrosome cycle and are critical mediators of centrosome amplification in p53-null cells.

Authors:  Arsene M Adon; Xiangbin Zeng; Mary K Harrison; Stacy Sannem; Hiroaki Kiyokawa; Philipp Kaldis; Harold I Saavedra
Journal:  Mol Cell Biol       Date:  2009-11-23       Impact factor: 4.272

10.  Cdk2 plays a critical role in hepatocyte cell cycle progression and survival in the setting of cyclin D1 expression in vivo.

Authors:  Eric A Hanse; Christopher J Nelsen; Melissa M Goggin; Chelsea K Anttila; Lisa K Mullany; Cyril Berthet; Philipp Kaldis; Gretchen S Crary; Ryoko Kuriyama; Jeffrey H Albrecht
Journal:  Cell Cycle       Date:  2009-09-08       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.